在乳腺外的帕杰特病中,遗传性 intratumour异质性和克隆进化
Kenichiro Tanaka1, Ikko Kajihara1, Kazuro Shimokawa2
1Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan.
European journal of dermatology : EJD
|June 22, 2024
概括
乳腺外帕杰特病 (EMPD) 呈现出显著的内瘤异质性 (ITH),大多数突变是私有的. 共同的背景因素,包括基替代和突变特征,影响EMPD瘤进化.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 基因组学就是基因组学.
背景情况:
- 瘤内异质性 (ITH) 描述了单个瘤内的遗传多样性.
- 多区域测序分析空间分离的组织,以了解ITH和瘤进化.
- 之前的研究发现了乳腺外帕杰特病 (EMPD) 的遗传突变,但并没有使用多区域测序来确定其ITH.
研究的目的:
- 澄清乳外帕杰特病 (EMPD) 中的 intratumoural异质性 (ITH) 和瘤演变的情况.
主要方法:
- 在5名EMPD患者的35个组织上进行了全外体测序.
- 分析包括30个瘤组织和5个配对的正常皮肤样本.
- 使用多区域测序方法来评估ITH.
主要成果:
- 在EMPD中,私有突变明显比无处不在或共享突变更为普遍.
- 驱动基因主要显示私人和共享突变,没有无处不在的驱动突变.
- 常见基因替代是C>T;突变特征1,2,3和8是普遍存在的.
- 瘤进化树显示短干和长枝,表明高的私有突变率.
- 病原性因素,如基替代,突变特征和拟议的病因学,在病变中共享.
结论:
- EMPD的特点是高程度的遗传内瘤异质性 (ITH).
- 在EMPD中的瘤进化是由高比例的私人突变驱动的.
- 共享的背景因素有助于EMPD的整体病原性情景.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


